Sweat Smart: New Biomarker Tech Revolutionizes Health Monitoring

  • 📰 SciTechDaily1
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 68%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Science, Space and Technology News 2024

Researchers from KIST and Northwestern University developed a new device that monitors health conditions through sweat analysis without requiring physical activity. This device, which uses drug-stimulated sweat production, offers a painless alternative to blood tests and is particularly useful for individuals with limited mobility. Credit: SciTechDaily.com

Illustration and photograph of the device capable of drug delivery for sweat induction and simultaneous monitoring of biomarkers in sweat. Credit: Korea Institute of Science and Technologyjointly announced the development of a convenient sweat monitoring device that does not require physical activity but delivers drug stimulation through the skin. Unlike previous methods that induced sweat through exercise, this device delivers drugs that stimulate sweat glands through the skin.

Additionally, the stability of the device on the skin was ensured by confirming skin temperature and pH values. Since cystic fibrosis mainly manifests during infancy, continuous monitoring of disease progression and physical condition is necessary. With this device, monitoring can be easily done at home, reducing the psychological and physical stress on pediatric patients and their caregivers.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 84. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Newly identified PET biomarker predicts success of immune checkpoint blockade therapyThe protein galectin-1 (Gal-1) has been identified as a new PET imaging biomarker for immune checkpoint blockade (ICB) therapy, allowing physicians to predict the tumor responses before beginning treatment.
Source: ScienceDaily - 🏆 452. / 53 Read more »